Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery Essay

Pages: 9 (2831 words)  ·  Bibliography Sources: 5  ·  File: .docx  ·  Level: Master's  ·  Topic: Health - Nursing

Medical and Medicine

Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery

Hyperglycemia is a condition that occurs frequently in patients during cardiac surgery. This condition can occur whether the patient has diabetes or not. Research has found that both intraoperative and postoperative glucose measurements can be important predictors of outcomes after cardiac surgery. Postoperative, but not intraoperative, glycemic variability has been found to have an effect on morbidity and mortality. The research that has been conducted to date is very inconsistent in its findings as to what factors are important and which ones are not. There have also been discrepancies on the idea of glucose control during surgery. These inconsistencies leave a lot of room for further research in this area in order to further pinpoint what factors are important and how each of these factors influences the outcomes of patients who undergo cardiac surgery.


Hyperglycemia is a condition that frequently occurs in patients during cardiopulmonary bypass surgery1. This condition is not necessarily dependent on whether a person had diabetes prior to surgery. Severe hyperglycemia has often been associated with unfavorable outcomes after cardiac surgery. Several studies have been done on whether intraoperative and postoperative glucose concentrations have equal impact outcomes of surgery patients. A solid conclusion has yet to be determined 2. Historically Perioperative hyperglycemia has not been treated because it was not thought to be harmful.

Buy full Download Microsoft Word File paper
for $19.77
Hyperglycemia is thought to be linked to adverse outcomes through both direct and indirect mechanisms. Hyperglycemia interferes with monocyte and neutrophil function, affects endothelial function and induces the expression of proinflamatory cytokines. These events are thought to be responsible for a directly negative effect of hyperglycemia, including the facilitation of wound infection or sepsis1.

Essay on Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery Assignment

Conventionally, diabetes mellitus (DM) has been associated with poor clinical outcomes after cardiac surgery. This has included a higher frequency of wound infections, ischemic events, neurological and renal complications, and mortality. The frequency of DM has greatly done up in developed countries, over the past decade. Knowledge of the patients' diabetic status preoperatively has led to advances in Perioperative clinical management that has included active and continuous blood glucose control (BGC). This has lead to improved clinical outcomes4.


I conducted a literature search using the Google Scholar, EBSCO MegaFile and PubMed databases. The following search terms were used: perioperative glucose control, intraoperative glucose control, Perioperative glucose control CABG and CABG glucose control. I used only human studied that were published in English.

Three retrospective studies were selected for review. One was a random controlled study while one was a non-randomized study.


. Prevention of hyperglycemia might not reduce Perioperative difficulties, and the risks and costs of intensive intraoperative glycemic management may outweigh the benefits. Research has shown that an association between intraoperative hyperglycemia and adverse outcomes based on observational studies does not prove causality. Because hyperglycemia can have negative effects such as reduced immunity, wound healing, and vascular function, the idea that normoglycemia be upheld during the relatively brief duration of cardiac surgery seems reasonable. Some experts feel that the degree of intraoperative hyperglycemia is thought to be merely a reflection of the severity of underlying stress. Others feel that simple, safe, and effective insulin infusion algorithms that are needed in order to achieve rigorous intraoperative glycemic control are missing. In order to look at this issue, Gandhi, et al., (2007), conducted a randomized, controlled trial in order to determine whether maintenance of near normoglycemia during cardiac surgery by using intraoperative intravenous insulin infusion reduced Perioperative death and morbidity.

The results of this study showed that when intensive intravenous intraoperative insulin therapy was used in a controlled setting, it preserved glucose concentrations close to normal during surgery without increasing the risk for hypoglycemia. These results contradicted previous observational studies that showed that intraoperative hyperglycemia strongly predicted unfavorable postoperative outcomes after adjustment for the effects of postoperative glucose levels. This study also showed that lowering glucose concentrations to near normal levels intra-operatively by intravenous insulin infusion did not decrease short-term death, morbidity, or length of stay in the ICU or hospital. On the other hand, the increased incidence of death and stroke in the intensive treatment group brought about a concern in regards to routine implementation of this intervention 1.

Over the last decade, a large amount of evidence has brought to light the advances in intraoperative and intensive care techniques for diabetes mellitus patients undergoing cardiac surgery with improved outcomes.

In this study postoperative blood glucose levels were looked examined 8,727 patients. Results showed that 7,457 (85.4%) had good, 905 (10.4%) had moderate, and 365 (4.2%) had poor BGC in the first 60 hours following surgery. Patients who had moderate or poor BGC were thought to be more likely to have had a history of congestive heart failure, hypertension, arrhythmia or renal failure. The researchers found that 48.2% of patients who were in the poor BGC group and 68.5% who were in the moderate group were nondiabetic. They did find though that moderate BGC and poor BGC were more prevalent among DM patients. Overall, the study found that the number of patients with insufficient BGC declined over time 4.

In a study done by Duncan, Abd-Elasyed, Maheshwari, Xu, Soltesz and Kock, (2010), an investigation was done in order to compare the ability of perioperative glucose concentrations and glycemic variability to predict adverse outcomes. Risk associated with diminishing increments of glucose concentrations, hypoglycemia and diabetic status was also looked at. The patient population of this study included 4,302 patients who had undergone cardiac surgery. The results of this study showed that patients with diabetes had poorer outcomes compared to those patients without diabetes. The occurrence of diabetes almost doubled the danger of mortality. On the other hand, no relationship was found between the presence of diabetes and the influence of hyperglycemia on outcomes. Patients who had diabetes, even though they were at increased risk for adverse outcomes because of having diabetes, were found to have the same risk as patients without diabetes in regards to the degree of hyperglycemia.

In a study done by Furnary, Wu and Bookin, (2004), The Portland Diabetic Project, looked at the adverse relationship between hyperglycemia and outcomes of cardiac surgical procedures in patients with diabetes and delineated the protective effects of intravenous insulin therapy in reducing these adverse outcomes. This was a 17-year prospective, nonrandomized, interventional study involving 4,864 patients who had diabetes and who had undergone an open-heart surgical procedure. They looked into the effects of hyperglycemia, and its resulting reduction by continuous intravenous insulin (CII) therapy. High blood glucose levels were found to be directly related to increasing rates of death, deep sternal wound infections (DSWI), length of stays (LOS), and overall costs. In a separate multivariate analysis that was conducted it was found that increasing hyperglycemia was an independent projector of increasing mortality.

In a study done by Doenst, Wijeysundera, Karkouti, Zechner, Maganti, Rae and Borger, (2005), the influence of hyperglycemia during cardiopulmonary bypass on perioperative morbidity and mortality in diabetic and nondiabetic patients was examined. Results showed that the overall mortality rate was 1.8%. High glucose intensity during cardiopulmonary bypass was found to be an independent forecaster of mortality in both diabetic and nondiabetic patients. It was found that a high glucose level during cardiopulmonary bypass was also an autonomous predictor of all major adverse events in both groups of patients. It was found that a high glucose level was not directly correlated to cardiopulmonary bypass. It has been determined that a high serum glucose level measured during cardiopulmonary bypass is an independent risk cause for both death and morbidity in diabetic patients and nondiabetic patients alike.

This study also ascertained that hyperglycemia can be linked with adverse postoperative outcomes with both diabetic and nondiabetic patients. These researchers have suggested that hyperglycemia is a sign of a state of insulin resistance that is often developed during surgical intervention and that this insulin resistance contributes to poor outcomes, rather than the hyperglycemia by itself. They speculated that the treatment of insulin resistance might improve outcomes in all patients undergoing cardiac surgery3.


This research has shown that hyperglycemia can be associated with negative outcomes after cardiac surgery and that this relationship is there in both diabetic and nondiabetic patients. Furnary, et al., (2004), established a direct relationship between postoperative glucose levels and mortality in patients with DM5. Other research found that both intraoperative and postoperative glucose measurements are important predictors of outcomes after cardiac surgery. In addition, postoperative, but not intraoperative, glycemic variability has been found to have an independent effect on morbidity and mortality2. In the study done by Gandhi, et al., (2007), glucous-insuline-potasium infusions were initiated just before anesthetic induction and for 12 hours following surgery. Patients who received these infusions were shown to have substantially lower incidences of atrial fibrillation than did those patients who received the standard therapy. It was also found that this group had shorter times of postoperative care along with shorter hospital stays. Patients who were given… [END OF PREVIEW] . . . READ MORE

Two Ordering Options:

Which Option Should I Choose?
1.  Buy full paper (9 pages)Download Microsoft Word File

Download the perfectly formatted MS Word file!

- or -

2.  Write a NEW paper for me!✍🏻

We'll follow your exact instructions!
Chat with the writer 24/7.

Coronary Artery Bypass Graft Surgery Term Paper

Coronary Artery Disease (CAD) Is a Frightening Term Paper

Pathophysiology of Coronary Artery Disease When Atheromatous Term Paper

Technical Instructions for Coronary Artery Bypass Graph Thesis

Coronary Artery Disease and Coronary Heart Research Paper

View 200+ other related papers  >>

How to Cite "Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery" Essay in a Bibliography:

APA Style

Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery.  (2010, June 22).  Retrieved June 6, 2020, from

MLA Format

"Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery."  22 June 2010.  Web.  6 June 2020. <>.

Chicago Style

"Perioperative Serum Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery."  June 22, 2010.  Accessed June 6, 2020.